Global Infliximab and biosimilar Market Research Report 2020


This report focuses on Infliximab and biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Infliximab and biosimilar market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Janssen Biotech
    Merck and Co.
    Pfizer
    ...

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Infliximab
    infliximab-dyyb
    infliximab-abda

Segment by Application
    Crohn's Disease
    Pediatric Crohn's Disease
    Ulcerative Colitis
    Rheumatoid Arthritis
    Ankylosing Spondylitis
    Psoriatic Arthritis
    Plaque Psoriasis
Table of Contents

1 Infliximab and biosimilar Market Overview
    1.1 Product Overview and Scope of Infliximab and biosimilar
    1.2 Infliximab and biosimilar Segment by Type
        1.2.1 Global Infliximab and biosimilar Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 Infliximab
        1.2.3 infliximab-dyyb
        1.2.4 infliximab-abda
    1.3 Infliximab and biosimilar Segment by Application
        1.3.1 Infliximab and biosimilar Sales Comparison by Application: 2020 VS 2026
        1.3.2 Crohn's Disease
        1.3.3 Pediatric Crohn's Disease
        1.3.4 Ulcerative Colitis
        1.3.5 Rheumatoid Arthritis
        1.3.6 Ankylosing Spondylitis
        1.3.7 Psoriatic Arthritis
        1.3.8 Plaque Psoriasis
    1.4 Global Infliximab and biosimilar Market Size Estimates and Forecasts
        1.4.1 Global Infliximab and biosimilar Revenue 2015-2026
        1.4.2 Global Infliximab and biosimilar Sales 2015-2026
        1.4.3 Infliximab and biosimilar Market Size by Region: 2020 Versus 2026

2 Global Infliximab and biosimilar Market Competition by Manufacturers
    2.1 Global Infliximab and biosimilar Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Infliximab and biosimilar Revenue Share by Manufacturers (2015-2020)
    2.3 Global Infliximab and biosimilar Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Infliximab and biosimilar Manufacturing Sites, Area Served, Product Type
    2.5 Infliximab and biosimilar Market Competitive Situation and Trends
        2.5.1 Infliximab and biosimilar Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Infliximab and biosimilar Players (Opinion Leaders)

3 Infliximab and biosimilar Retrospective Market Scenario by Region
    3.1 Global Infliximab and biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Infliximab and biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Infliximab and biosimilar Market Facts & Figures by Country
        3.3.1 North America Infliximab and biosimilar Sales by Country
        3.3.2 North America Infliximab and biosimilar Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Infliximab and biosimilar Market Facts & Figures by Country
        3.4.1 Europe Infliximab and biosimilar Sales by Country
        3.4.2 Europe Infliximab and biosimilar Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Infliximab and biosimilar Market Facts & Figures by Region
        3.5.1 Asia Pacific Infliximab and biosimilar Sales by Region
        3.5.2 Asia Pacific Infliximab and biosimilar Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Infliximab and biosimilar Market Facts & Figures by Country
        3.6.1 Latin America Infliximab and biosimilar Sales by Country
        3.6.2 Latin America Infliximab and biosimilar Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Infliximab and biosimilar Market Facts & Figures by Country
        3.7.1 Middle East and Africa Infliximab and biosimilar Sales by Country
        3.7.2 Middle East and Africa Infliximab and biosimilar Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Infliximab and biosimilar Historic Market Analysis by Type
    4.1 Global Infliximab and biosimilar Sales Market Share by Type (2015-2020)
    4.2 Global Infliximab and biosimilar Revenue Market Share by Type (2015-2020)
    4.3 Global Infliximab and biosimilar Price Market Share by Type (2015-2020)
    4.4 Global Infliximab and biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Infliximab and biosimilar Historic Market Analysis by Application
    5.1 Global Infliximab and biosimilar Sales Market Share by Application (2015-2020)
    5.2 Global Infliximab and biosimilar Revenue Market Share by Application (2015-2020)
    5.3 Global Infliximab and biosimilar Price by Application (2015-2020)

6 Company Profiles and Key Figures in Infliximab and biosimilar Business
    6.1 Janssen Biotech
        6.1.1 Corporation Information
        6.1.2 Janssen Biotech Description, Business Overview and Total Revenue
        6.1.3 Janssen Biotech Infliximab and biosimilar Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Janssen Biotech Products Offered
        6.1.5 Janssen Biotech Recent Development
    6.2 Merck and Co.
        6.2.1 Merck and Co. Infliximab and biosimilar Production Sites and Area Served
        6.2.2 Merck and Co. Description, Business Overview and Total Revenue
        6.2.3 Merck and Co. Infliximab and biosimilar Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Merck and Co. Products Offered
        6.2.5 Merck and Co. Recent Development
    6.3 Pfizer
        6.3.1 Pfizer Infliximab and biosimilar Production Sites and Area Served
        6.3.2 Pfizer Description, Business Overview and Total Revenue
        6.3.3 Pfizer Infliximab and biosimilar Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Pfizer Products Offered
        6.3.5 Pfizer Recent Development

7 Infliximab and biosimilar Manufacturing Cost Analysis
    7.1 Infliximab and biosimilar Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Infliximab and biosimilar
    7.4 Infliximab and biosimilar Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Infliximab and biosimilar Distributors List
    8.3 Infliximab and biosimilar Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Infliximab and biosimilar Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Infliximab and biosimilar by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Infliximab and biosimilar by Type (2021-2026)
    10.2 Infliximab and biosimilar Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Infliximab and biosimilar by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Infliximab and biosimilar by Application (2021-2026)
    10.3 Infliximab and biosimilar Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Infliximab and biosimilar by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Infliximab and biosimilar by Region (2021-2026)
    10.4 North America Infliximab and biosimilar Estimates and Projections (2021-2026)
    10.5 Europe Infliximab and biosimilar Estimates and Projections (2021-2026)
    10.6 Asia Pacific Infliximab and biosimilar Estimates and Projections (2021-2026)
    10.7 Latin America Infliximab and biosimilar Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Infliximab and biosimilar Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Infliximab and biosimilar Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Infliximab and biosimilar Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Infliximab and biosimilar Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Infliximab and biosimilar Manufacturers Covered in This Study Table 5. Global Infliximab and biosimilar Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Infliximab and biosimilar Sales Share by Manufacturers (2015-2020) Table 7. Global Infliximab and biosimilar Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Infliximab and biosimilar Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Infliximab and biosimilar Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Infliximab and biosimilar Sales Sites and Area Served Table 11. Manufacturers Infliximab and biosimilar Product Types Table 12. Global Infliximab and biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Infliximab and biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infliximab and biosimilar as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Infliximab and biosimilar Players Table 16. Global Infliximab and biosimilar Sales (K MT) by Region (2015-2020) Table 17. Global Infliximab and biosimilar Sales Market Share by Region (2015-2020) Table 18. Global Infliximab and biosimilar Revenue (Million US$) by Region (2015-2020) Table 19. Global Infliximab and biosimilar Revenue Market Share by Region (2015-2020) Table 20. North America Infliximab and biosimilar Sales by Country (2015-2020) (K MT) Table 21. North America Infliximab and biosimilar Sales Market Share by Country (2015-2020) Table 22. North America Infliximab and biosimilar Revenue by Country (2015-2020) (US$ Million) Table 23. North America Infliximab and biosimilar Revenue Market Share by Country (2015-2020) Table 24. Europe Infliximab and biosimilar Sales by Country (2015-2020) (K MT) Table 25. Europe Infliximab and biosimilar Sales Market Share by Country (2015-2020) Table 26. Europe Infliximab and biosimilar Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Infliximab and biosimilar Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Infliximab and biosimilar Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Infliximab and biosimilar Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Infliximab and biosimilar Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Infliximab and biosimilar Revenue Market Share by Region (2015-2020) Table 32. Latin America Infliximab and biosimilar Sales by Country (2015-2020) (K MT) Table 33. Latin America Infliximab and biosimilar Sales Market Share by Country (2015-2020) Table 34. Latin America Infliximab and biosimilar Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Infliximab and biosimilar Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Infliximab and biosimilar Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Infliximab and biosimilar Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Infliximab and biosimilar Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Infliximab and biosimilar Revenue Market Share by Country (2015-2020) Table 40. Global Infliximab and biosimilar Sales (K MT) by Type (2015-2020) Table 41. Global Infliximab and biosimilar Sales Share by Type (2015-2020) Table 42. Global Infliximab and biosimilar Revenue (Million US$) by Type (2015-2020) Table 43. Global Infliximab and biosimilar Revenue Share by Type (2015-2020) Table 44. Global Infliximab and biosimilar Price (USD/MT) by Type (2015-2020) Table 45. Global Infliximab and biosimilar Sales (K MT) by Application (2015-2020) Table 46. Global Infliximab and biosimilar Sales Market Share by Application (2015-2020) Table 47. Global Infliximab and biosimilar Sales Growth Rate by Application (2015-2020) Table 48. Janssen Biotech Infliximab and biosimilar Corporation Information Table 49. Janssen Biotech Description and Business Overview Table 50. Janssen Biotech Infliximab and biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Janssen Biotech Main Product Table 52. Janssen Biotech Recent Development Table 53. Merck and Co. Infliximab and biosimilar Corporation Information Table 54. Merck and Co. Corporation Information Table 55. Merck and Co. Infliximab and biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Merck and Co. Main Product Table 57. Merck and Co. Recent Development Table 58. Pfizer Infliximab and biosimilar Corporation Information Table 59. Pfizer Corporation Information Table 60. Pfizer Infliximab and biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Pfizer Main Product Table 62. Pfizer Recent Development Table 63. Sales Base and Market Concentration Rate of Raw Material Table 64. Key Suppliers of Raw Materials Table 65. Infliximab and biosimilar Distributors List Table 66. Infliximab and biosimilar Customers List Table 67. Market Key Trends Table 68. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 69. Key Challenges Table 70. Global Infliximab and biosimilar Sales (K MT) Forecast by Type (2021-2026) Table 71. Global Infliximab and biosimilar Sales Market Share Forecast by Type (2021-2026) Table 72. Global Infliximab and biosimilar Revenue (Million US$) Forecast by Type (2021-2026) Table 73. Global Infliximab and biosimilar Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 74. Global Infliximab and biosimilar Sales (K MT) Forecast by Application (2021-2026) Table 75. Global Infliximab and biosimilar Revenue (Million US$) Forecast by Application (2021-2026) Table 76. Global Infliximab and biosimilar Sales (K MT) Forecast by Region (2021-2026) Table 77. Global Infliximab and biosimilar Sales Market Share Forecast by Region (2021-2026) Table 78. Global Infliximab and biosimilar Revenue Forecast by Region (2021-2026) (US$ Million) Table 79. Global Infliximab and biosimilar Revenue Market Share Forecast by Region (2021-2026) Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Infliximab and biosimilar Figure 2. Global Infliximab and biosimilar Sales Market Share by Type: 2020 VS 2026 Figure 3. Infliximab Product Picture Figure 4. infliximab-dyyb Product Picture Figure 5. infliximab-abda Product Picture Figure 6. Global Infliximab and biosimilar Consumption Market Share by Application: 2020 VS 2026 Figure 7. Crohn's Disease Figure 8. Pediatric Crohn's Disease Figure 9. Ulcerative Colitis Figure 10. Rheumatoid Arthritis Figure 11. Ankylosing Spondylitis Figure 12. Psoriatic Arthritis Figure 13. Plaque Psoriasis Figure 14. Global Infliximab and biosimilar Market Size 2015-2026 (US$ Million) Figure 15. Global Infliximab and biosimilar Sales Capacity (K MT) (2015-2026) Figure 16. Global Infliximab and biosimilar Market Size Market Share by Region: 2020 Versus 2026 Figure 17. Infliximab and biosimilar Sales Share by Manufacturers in 2020 Figure 18. Global Infliximab and biosimilar Revenue Share by Manufacturers in 2019 Figure 19. The Global 5 and 10 Largest Players: Market Share by Infliximab and biosimilar Revenue in 2019 Figure 20. Infliximab and biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Global Infliximab and biosimilar Sales Market Share by Region (2015-2020) Figure 22. Global Infliximab and biosimilar Sales Market Share by Region in 2019 Figure 23. Global Infliximab and biosimilar Revenue Market Share by Region (2015-2020) Figure 24. Global Infliximab and biosimilar Revenue Market Share by Region in 2019 Figure 25. North America Infliximab and biosimilar Sales Market Share by Country in 2019 Figure 26. North America Infliximab and biosimilar Revenue Market Share by Country in 2019 Figure 27. U.S. Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 28. U.S. Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Canada Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 30. Canada Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. Europe Infliximab and biosimilar Sales Market Share by Country in 2019 Figure 32. Europe Infliximab and biosimilar Revenue Market Share by Country in 2019 Figure 33. Germany Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 34. Germany Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. France Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 36. France Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. U.K. Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 38. U.K. Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Italy Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 40. Italy Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Russia Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 42. Russia Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Asia Pacific Infliximab and biosimilar Sales Market Share by Region in 2019 Figure 44. Asia Pacific Infliximab and biosimilar Revenue Market Share by Region in 2019 Figure 45. China Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 46. China Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Japan Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 48. Japan Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. South Korea Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 50. South Korea Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. India Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 52. India Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Australia Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 54. Australia Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Taiwan Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 56. Taiwan Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Indonesia Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 58. Indonesia Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Thailand Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 60. Thailand Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Malaysia Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 62. Malaysia Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Philippines Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 64. Philippines Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Vietnam Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 66. Vietnam Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Latin America Infliximab and biosimilar Sales Market Share by Country in 2019 Figure 68. Latin America Infliximab and biosimilar Revenue Market Share by Country in 2019 Figure 69. Mexico Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 70. Mexico Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Brazil Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 72. Brazil Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Argentina Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 74. Argentina Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Middle East and Africa Infliximab and biosimilar Sales Market Share by Country in 2019 Figure 76. Middle East and Africa Infliximab and biosimilar Revenue Market Share by Country in 2019 Figure 77. Turkey Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 78. Turkey Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Saudi Arabia Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 80. Saudi Arabia Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. U.A.E Infliximab and biosimilar Sales Growth Rate (2015-2020) (K MT) Figure 82. U.A.E Infliximab and biosimilar Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Sales Market Share of Infliximab and biosimilar by Type (2015-2020) Figure 84. Sales Market Share of Infliximab and biosimilar by Type in 2019 Figure 85. Revenue Share of Infliximab and biosimilar by Type (2015-2020) Figure 86. Revenue Market Share of Infliximab and biosimilar by Type in 2019 Figure 87. Global Infliximab and biosimilar Sales Growth by Type (2015-2020) (K MT) Figure 88. Global Infliximab and biosimilar Sales Market Share by Application (2015-2020) Figure 89. Global Infliximab and biosimilar Sales Market Share by Application in 2019 Figure 90. Global Revenue Share of Infliximab and biosimilar by Application (2015-2020) Figure 91. Global Revenue Share of Infliximab and biosimilar by Application in 2020 Figure 92. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Merck and Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Price Trend of Key Raw Materials Figure 96. Manufacturing Cost Structure of Infliximab and biosimilar Figure 97. Manufacturing Process Analysis of Infliximab and biosimilar Figure 98. Infliximab and biosimilar Industrial Chain Analysis Figure 99. Channels of Distribution Figure 100. Distributors Profiles Figure 101. Porter's Five Forces Analysis Figure 102. North America Infliximab and biosimilar Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 103. North America Infliximab and biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Europe Infliximab and biosimilar Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 105. Europe Infliximab and biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Latin America Infliximab and biosimilar Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 107. Latin America Infliximab and biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Middle East and Africa Infliximab and biosimilar Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 109. Middle East and Africa Infliximab and biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Asia Pacific Infliximab and biosimilar Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 111. Asia Pacific Infliximab and biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Other Reports by QY Research

Global E-paper Display Market Research Report 2020

This report focuses on E-paper Display volume and value at global level, regional level and company level. From a global perspective, this report represents overall E-paper Display market size by analyzing historical data and future prospect. Regiona...

Global Varicose Vein Treatment Device Market Research Report 2020

This report focuses on Varicose Vein Treatment Device volume and value at global level, regional level and company level. From a global perspective, this report represents overall Varicose Vein Treatment Device market size by analyzing historical dat...

Global Wi-Fi Chipset Market Research Report 2020

This report focuses on Wi-Fi Chipset volume and value at global level, regional level and company level. From a global perspective, this report represents overall Wi-Fi Chipset market size by analyzing historical data and future prospect. Regionally,...

Global Salicylic Acid Market Research Report 2020

This report focuses on Salicylic Acid volume and value at global level, regional level and company level. From a global perspective, this report represents overall Salicylic Acid market size by analyzing historical data and future prospect. Regionall...

Global Acetylsalicylic Acid Market Research Report 2020

This report focuses on Acetylsalicylic Acid volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acetylsalicylic Acid market size by analyzing historical data and future prospec...

Publisher: QY Research